According to our report, the size of the Bioinformatics Market in the Asia Pacific was worth USD 1.99 billion in 2020 and estimated to be growing at a CAGR of 21.4%, to reach USD 5.24 billion by 2025.
In the field of Bioinformatics, biological data is interpreted through the use and development of new software methods and tools. It is an interdisciplinary field comprising of subjects like computer science, mathematics, engineering, and statistics to analyze the biological information acquired. Bioinformatics involves all the biological studies which are done by using computer programming as the tool. Bioinformatics is used mainly for knowing candidate genes and single nucleotide polymorphisms.
Bioinformatics finds its application in many areas of biology. It assists in obtaining useful information from the text and in gene ontology to name and organize data. In the field of genomics and genetics, it helps in sequencing genomes and noting their mutations. In the field of experimental molecular biology, it finds its applications in the forms of techniques such as image and signal processing. It helps interpret evolutionary aspects of molecular biology by comparing the obtained genetic and genomic data. It also helps in analyzing gene and protein expression and regulation.
The driving factors of Asia-Pacific Bioinformatics market are growing need for sequencing protein and nucleic acids, rising assistance of this field in manufacturing new medicines and clinical diagnostics, increasing initiatives from the government, rising demand for integrated bioinformatics systems in proteomics and genomics, an increasing number of partnerships between research organizations and companies among others.
The constraints of this market are high costs, lack of skilled workers, lack of user-friendly tools and lack of interoperability among various data formats.
This research report has been segmented & sub-segmented into the following categories:
Based on the sector, the Medical biotechnology segment accounted for the largest share in this segment, owing to the growing need for developing new drugs at low prices.
Based on products & services, the Knowledge management tools segment has the largest share in this segment and bioinformatics platforms are the fastest-growing sub-segment.
In the applications, the Genomics segment accounts for the largest market share in the applications segment.
Regionally, Asia-Pacific is the fastest-growing region globally. Factors such as rising demand for protein and nucleic acid sequencing, increased funding for research and growing demand for research in proteomics and genomics are expected to drive the growth of this market.
The Chinese bioinformatics market is expected to account for the largest share in this region during the forecast period. Factors such as modern healthcare infrastructure, growing perforation of cutting-edge research and clinical laboratory techniques are driving the bioinformatics market of this APAC region.
Bioinformatics market in Japan and India countries are projected to grow healthy CAGR over the analysis period. Factors responsible for the growth are advance technologies, increasing the speed of decoding genetic sequences are accelerating the market growth. However, shortage of skilled bioinformatics professionals, high cost and lack of interaction are such factors hampering the growth.
Most promising companies operating in the APAC Bioinformatics Market profiled in this report are Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc. and Waters Corporation among others.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.1 Animal Biotechnology
5.1.2 Environmental Biotechnology
188.8.131.52 Alternative Energy Sources
184.108.40.206 Waste Clean-Up/Bioremediation
220.127.116.11 Climate Change Studies
5.1.3 Agricultural Biotechnology
18.104.22.168 Crop Yield Improvement
22.214.171.124 Pest Resistance
126.96.36.199 Improvement of Plant Resistance
188.8.131.52 Biodiversity Informatics
184.108.40.206 Nutritional Quality Improvement
5.1.4 Forensic Biotechnology
5.1.5 Medical Biotechnology
220.127.116.11 Drug Development
18.104.22.168 Clinical Diagnostics
22.214.171.124 Molecular Medicine
126.96.36.199.1 Personalized Medicine
188.8.131.52.2 Preventive Medicine
184.108.40.206 Gene Therapy
220.127.116.11 Reproductive Biotechnology
5.1.7 Other sectors
5.1.8 Y-o-Y Growth Analysis, By Sector
5.1.9 Market Attractiveness Analysis, By Sector
5.1.10 Market Share Analysis, By Sector
5.2 Products and Services
5.2.1 Bioinformatics Platforms
18.104.22.168 Sequence Analysis Platforms
22.214.171.124 Sequence Alignment Platforms
126.96.36.199 Sequence Manipulation Platforms
188.8.131.52 Structural and Functional Analysis Platforms
184.108.40.206 Other Bioinformatics Platforms
5.2.2 Knowledge Management Tools
220.127.116.11 Generalized Knowledge Management Tools
18.104.22.168 Specialized Knowledge Management Tools
5.2.3 Bioinformatics Services
22.214.171.124 Data Analysis
126.96.36.199 Sequencing Services
188.8.131.52 Other Bioinformatics Services
184.108.40.206 Database and Management Services
5.2.4 Y-o-Y Growth Analysis, By Products and Services
5.2.5 Market Attractiveness Analysis, By Products and Services
5.2.6 Market Share Analysis, By Products and Services
5.3.3 Molecular Phylogenetics
5.3.5 Drug Design and Genomics
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Sector
18.104.22.168 By Products and Services
22.214.171.124 By Application
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Sector
188.8.131.52 By Products and Services
184.108.40.206 By Application
6.1.5 Market Share Analysis
220.127.116.11 By Sector
18.104.22.168 By Products and Services
22.214.171.124 By Application
6.5 South Korea
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Agilent Technologies
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Affymetrix Inc.
8.3 Applied Biological Materials (ABM)
8.4 3rd Millenium Inc.
8.5 Illumina Inc.,
8.6 Thermo Fisher Scientific Inc.
8.7 Qiagen N.V.
8.8 Biomax Informatics Ag
8.9 DNAnexus, Inc.
8.10 Waters Corporation
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures